Literature DB >> 6975356

Imbalances in T-cell subpopulations in myasthenia gravis.

H C Chiu, K H Hsieh, T P Hung.   

Abstract

Distributions of peripheral blood lymphocyte subpopulations and T-cell subsets were studied in 38 patients with myasthenia gravis (MG) and 23 healthy controls. T cells were detected by rosette formation with sheep red blood cells and B cells with erythrocyte-antibody-complement (EAC) complexes. T mu cells were identified by rosette formation of T cells with Ox RBC-IgM complexes, and T gamma cells with Ox RBC-IgG complexes. The means of total lymphocyte count and active T cell percentage were marginally significantly lower in MG patients than in normal controls (0.05 less than P less than 0.1). The mean percentage of T mu cells was higher in MG patients than in controls (50.2 +/- 11.8% vs. 38.5 +/- 15.3%, P less than 0.01), whereas that of T gamma cells in the former was lower than that in the latter (20.4 +/- 7.1% vs. 27.6 +/- 6.2%, P less than 0.001). Thus, the loss of regulatory suppressor T cells and the increase of helper T cells in the patients are in favour of regarding MG as an autoimmune disease. The fact that the percentage of T gamma cells was significantly decreased in MG patients after autologus serum incubation, and that no such a phenomenon was seen in normal controls, may suggest a possible role of serum factors in the pathogenesis of MG.

Entities:  

Mesh:

Year:  1981        PMID: 6975356     DOI: 10.1016/0022-510x(81)90133-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

1.  Lymphocyte populations in patients with myasthenia gravis. Influence of thymectomy and immunosuppressive drugs.

Authors:  G Ippoliti; G Piccolo; M Lombardi; G Carnevale Maffé; V Cosi; P Pinelli
Journal:  Ital J Neurol Sci       Date:  1982-12

Review 2.  The effect of thymectomy on myasthenia gravis, thrombocytopenia, and granulocytopenia associated with thymoma: report of a case.

Authors:  M Kobayashi; T Hasegawa; S Iwabuchi; M Fukushima; H Koie; K Kannari
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.